文献
J-GLOBAL ID:201902250654219872
整理番号:19A1834127
高いEmsY発現は,長期生存と白金に対する過敏症を伴う高悪性度漿液性卵巣癌のBRCA様サブグループを定義する【JST・京大機械翻訳】
High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum
著者 (21件):
Hollis Robert L.
(Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Edinburgh Centre, Medical Research Council Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom)
,
Churchman Michael
(Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Edinburgh Centre, Medical Research Council Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom)
,
Michie Caroline O.
(Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Edinburgh Centre, Medical Research Council Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom)
,
Rye Tzyvia
(Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Edinburgh Centre, Medical Research Council Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom)
,
Knight Laura
(Almac Diagnostics, Craigavon, United Kingdom)
,
McCavigan Andrena
(Almac Diagnostics, Craigavon, United Kingdom)
,
Perren Timothy
(St. James’s Institute of Oncology, St. James’s University Hospital, Leeds, United Kingdom)
,
Williams Alistair R. W.
(Department of Pathology, University of Edinburgh, Edinburgh, United Kingdom)
,
McCluggage W. Glenn
(Center for Cancer Research and Cell Biology, Queen’s University of Belfast, Belfast, United Kingdom)
,
McCluggage W. Glenn
(Department of Pathology, Belfast Health and Social Care Trust, Belfast, United Kingdom)
,
Kaplan Richard S.
(Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom)
,
Jayson Gordon C.
(Division of Molecular and Clinical Cancer Sciences, University of Manchester, Manchester, United Kingdom)
,
Oza Amit
(Cancer Clinical Research Unit, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada)
,
Harkin D. Paul
(Almac Diagnostics, Craigavon, United Kingdom)
,
Harkin D. Paul
(Center for Cancer Research and Cell Biology, Queen’s University of Belfast, Belfast, United Kingdom)
,
Herrington C. Simon
(Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Edinburgh Centre, Medical Research Council Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom)
,
Herrington C. Simon
(Department of Pathology, University of Edinburgh, Edinburgh, United Kingdom)
,
Herrington C. Simon
(Division of Pathology, Centre for Comparative Pathology, Cancer Research UK Edinburgh Centre, Medical Research Council Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom)
,
Kennedy Richard
(Almac Diagnostics, Craigavon, United Kingdom)
,
Kennedy Richard
(Center for Cancer Research and Cell Biology, Queen’s University of Belfast, Belfast, United Kingdom)
,
Gourley Charlie
(Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Edinburgh Centre, Medical Research Council Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom)
資料名:
Cancer (Hoboken, N.J.)
(Cancer (Hoboken, N.J.))
巻:
125
号:
16
ページ:
2772-2781
発行年:
2019年
JST資料番号:
D0781B
ISSN:
0008-543X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)